ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      85.255
      0.17%
      Bitcoin
      63,331.55
      1.06%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. AVEO Pharmaceuticals Inc (AVEO)

      7. AVEO Pharmaceuticals Inc (AVEO) News

      AVEO

      AVEO Pharmaceuticals (AVEO)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AVEO
      DateTimeSourceHeadlineSymbolCompany
      06/23/20175:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/23/20175:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/23/20178:37AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/23/20178:00AMBusiness WireAVEO Oncology Announces Positive CHMP Opinion for Tivozanib as a Treatment of Advanced Renal Cell CarcinomaNASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/20/20177:00AMBusiness WireAVEO Oncology Announces Pivotal Phase 3 TIVO-3 Study of Tivozanib in Renal Cell Carcinoma Reaches Enrollment TargetNASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/08/20174:22PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/08/20177:00AMBusiness WireAVEO Oncology Announces Phase 1/2 TiNivo Trial of Tivozanib and Opdivo® (nivolumab) in RCC Advances to Phase 2NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/05/20172:15PMBusiness WireAVEO Oncology & Biodesix Announce Results from Two Investigator-Sponsored Phase 1 Studies of HGF Targeted Antibody Ficlatuzum...NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/01/201711:23AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/01/201711:06AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/19/20177:00AMBusiness WireAVEO Oncology Announces Completion of a CHMP Oral Explanation for Tivozanib as a Treatment of First-Line Renal Cell CarcinomaNASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/17/20174:31PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/17/20174:29PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/16/20177:00AMBusiness WireAVEO Announces Appointment of Matthew Dallas as Chief Financial OfficerNASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/15/20179:30AMBusiness WireAVEO Issues Statement Regarding the Passing of Lead Director Henri A. TermeerNASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/08/20177:00AMBusiness WireAVEO Oncology Announces Receipt of USPTO Notice of Allowance Related to AV-353NASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/04/20178:13AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/04/20177:00AMBusiness WireAVEO Reports First Quarter 2017 Financial Results and Provides Business UpdateNASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/04/20176:17AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      04/27/20175:17PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      04/27/20175:12PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      04/20/201710:06AMBusiness WireAVEO Announces Presentations at the 2017 ASCO Annual MeetingNASDAQ:AVEOAVEO Pharmaceuticals Inc
      04/14/20175:29PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      04/13/20178:00AMBusiness WireAVEO Announces Submission of Response to Tivozanib Marketing Authorization Application Day 180 List of Outstanding IssuesNASDAQ:AVEOAVEO Pharmaceuticals Inc
      04/12/20177:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      04/05/20176:38AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      04/04/20174:44PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      04/03/20177:00AMBusiness WireAVEO Announces Milestone Payment from CANbridge for AV-203NASDAQ:AVEOAVEO Pharmaceuticals Inc
      03/31/20174:05PMBusiness WireAVEO Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional SharesNASDAQ:AVEOAVEO Pharmaceuticals Inc
      03/29/20174:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:AVEO

      Your Recent History

      BOV
      U2ST34Q
      Unity Software
      Delayed Upgrade Clock